✦ LIBER ✦

PCN89 DRUG UTILIZATION PATTERNS AND COSTS FOR ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) IN A MANAGED CARE CANCER POPULATION RECEIVING CHEMOTHERAPY

✍ Scribed by A Gosselin; MH Lafeuille; B Bookhart; P Lefebvre; RS Mckenzie; F Vekeman; CT Piech

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN25 DRUG UTILIZATION AND COSTS FOR ERY

✍ MH Lafeuille; RS McKenzie; F Vekeman; R Bailey; CT Piech; P Lefebvre 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PCN32 RECENT ERYTHROPOIESIS STIMULATING

✍ FK Kokkotos; RA Bailey; M Kerr; S Shen; M Senbetta; RS McKenzie 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PCN21 DRUG UTILIZATION, COST CONSIDERATI

✍ A Gosselin; M Duh; P Lefebvre; S Mody; B Bookhart; RS Mckenzie 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

CN1 RECENT ERYTHROPOIESIS-STIMULATING AG

✍ MH Lafeuille; R Bailey; F Vekeman; CT Piech; RS McKenzie; P Lefebvre 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

38: Drug Utilization Patterns and Costs

✍ Robert A. Bailey; François Laliberté; Marie-Hélène Lafeuille; Mekré Senbetta; R. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 94 KB